Anti-HCV E2 Recombinant Antibody (e137) (CAT#: MRO-1203LC)

This product is a recombinant human anti-Hepatitis C virus monoclonal antibody (e137). e137 and e8 were defined as recognizing two distinct epitopes on HCV/E2 and these epitopes were defined as nonneutralizing. e137 specifically binds to glycoprotein E2 associated with HCV and can be potentially used in the treatment and diagnosis of Hepatitis C virus infection.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
Neut

Figure 1 Critical residues abrogating mAb binding.

Figure 1 Critical residues abrogating mAb binding.

Antibodies are divided into neutralizers and non-neutralizers. Epitope residues are marked in red, while residues that are part of the CD81bs are underlined. The threshold below which a decrease in reactivity defines a residue as part of an epitope was determined for each antibody (e137 < 15%, e20 < 20%, e301 < 20%, e509 < 15%, e10 < 30%, e8 < 20%, H60 < 15%).

A Biologically-validated HCV E1E2 Heterodimer Structural Model

Neut

Figure 2 Inhibition of binding of probe FLAG-Fab antigen by previous binding of different concentrations of purified unlabeled Fabs used as competitors.

Figure 2 Inhibition of binding of probe FLAG-Fab antigen by previous binding of different concentrations of purified unlabeled Fabs used as competitors.

Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries

Neut

Figure 3 Inhibition of binding of human recombinant Fabs by previous binding of a 1:20 dilution of sera obtained from HCV-infected patients and from two HCV-negative controls.

Figure 3 Inhibition of binding of human recombinant Fabs by previous binding of a 1:20 dilution of sera obtained from HCV-infected patients and from two HCV-negative controls.

All HCV-positive sera were demonstrated to contain HCV RNA of genotype 1b and to have an ELISA titer against HCV/E2 of>1:500.


Specifications

  • Host Species
  • Human
  • Type
  • Human antibody
  • Specificity
  • Hepatitis C virus
  • Clone
  • e137
  • Applications
  • ELISA, Neut
  • Related Disease
  • Hepatitis C virus infection

Applications

  • Application Notes
  • The HCV E2 Protein antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Neutralization.

Target

  • Alternative Names
  • Hepatitis C virus; HCV; HCV E2; Hepatitis C virus E2

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone e137"

See other products for "HCV E2 protein"

MHC Tetramer for Virology

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-1203LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare